PROGRAMMED DEATH LIGAND-1 (PD-L1) EXPRESSION STATUS IN PENILE SQUAMOUS CELL CARCINOMA TUMOR CELLS AND TUMOR INFILTRATING IMMUNE CELLS

被引：0
|
作者：
Rider, Jennifer
Harlow, Alyssa
Giunchi, Francesca
Carlsson, Jessica
Kirrander, Peter
Fiorentino, Michelangelo
Andren, Ove
Davidsson, Sabina
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP84-13
引用
收藏
页码：E1129 / E1130
页数：2
相关论文
共 50 条
  • [21] Programmed Death Ligand-1 and Tumor Infiltrating Immune Cells in Non-Small Cell Lung Carcinoma, a Report from India
    Jain, Deepali
    Singh, Varsha
    Malik, Prabhat
    Kumar, Sunil
    LABORATORY INVESTIGATION, 2017, 97 : 480A - 480A
  • [22] PROGRAMMED DEATH-LIGAND (PD-L1) EXPRESSION AND LYMPH NODE INVOLVEMENT IN PENILE SQUAMOUS CELL CARCINOMA
    Peyroteo, Ines
    Santos, Filipa
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1010 - E1011
  • [23] Histological Subtype of Lung Adenocarcinoma and Programmed Death Ligand 1 (PD-L1) Expression in Tumor Cells
    Arrieta, O.
    Cruz-Rico, G.
    Aviles-Salas, A.
    Popa-Navarro, X.
    Flores-Velez, K. Y.
    Ramirez-Tirado, L.
    Vergara, E.
    Barron, F.
    Cabrera-Miranda, L. A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S162 - S162
  • [24] Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
    Feng, Yong
    Shen, Jacson
    Gao, Yan
    Liao, Yunfei
    Cote, Gregory
    Choy, Edwin
    Chebib, Ivan
    Mankin, Henry
    Hornicek, Francis
    Duan, Zhenfeng
    ONCOTARGET, 2015, 6 (13) : 11139 - 11149
  • [25] The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma
    Gabrych, Anna
    Peksa, Rafal
    Kunc, Michal
    Krawczyk, Malgorzata
    Izycka-Swieszewska, Ewa
    Biernat, Wojciech
    Bien, Ewa
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (12)
  • [26] Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma
    Soo Jeong Nam
    Young-Hoon Kim
    Ji Eun Park
    Young-shin Ra
    Shin Kwang Khang
    Young Hyun Cho
    Jeong Hoon Kim
    Chang Ohk Sung
    Cancer Immunology, Immunotherapy, 2019, 68 : 305 - 318
  • [27] Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma
    Nam, Soo Jeong
    Kim, Young-Hoon
    Park, Ji Eun
    Ra, Young-shin
    Khang, Shin Kwang
    Cho, Young Hyun
    Kim, Jeong Hoon
    Sung, Chang Ohk
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (02) : 305 - 318
  • [28] Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells
    Shwe, Thuzar Hla
    Pothacharoen, Peraphan
    Phitak, Thanyaluck
    Wudtiwai, Benjawan
    Kongtawelert, Prachya
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [29] The prognostic role of PD-L1 expression in tumor and immune cells in oral cavity squamous cell carcinoma
    Kutukova, S.
    Beliak, N.
    Manikhas, G.
    Raskin, G.
    Ivaskova, Y.
    Popova, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma
    Zoroquiain, Pablo
    Esposito, Evangelina
    Logan, Patrick
    Aldrees, Sultan
    Dias, Ana Beatriz
    Mansure, Jose Joao
    Santapau, Daniela
    Garcia, Ciro
    Saornil, Maria Antonia
    Neto, Rubens Belfort
    Burnier, Miguel N.
    MODERN PATHOLOGY, 2018, 31 (08) : 1201 - 1210
12345